Dinner program for Sarasota Memorial Hospital APRNs treating patients for heart failure.
Posted about 13 hours ago by Cynthia Drew
September 4 Dinner Program, 7:00 p.m., Fleming's UTC/Mangrove Room.
If you are an NP working with Heart Failure patients and are associated with Sarasota Memorial Hospital (Main or Venice), this program is designed for you.
Broadcast Date/Time: September 4th, 7pm EST / 9pm EST
Broadcast Title: “The Next Beat: KERENDIA for Your Patients with HF With LVEF ≥40%”
Broadcast Objectives:
- Reinforce current unmet needs in patients with HF with LVEF ≥40%
- The role of KERENDIA (Finerenone) as a selective, nonsteroidal mineralocorticoid receptor antagonist
- KERENDIA (Finerenone) is a new core pillar in comprehensive care to reduce the risk of CV death and total HF events in patients with HF with LVEF ≥40%.
Please RSVP to:
Toni Gray Almgren, ISS (Institutional & Specialty Sales)
Cardiovascular Renal
Bayer U.S. LLC/Pharmaceuticals
100 Bayer Boulevard
Whippany NJ 07981, United States
Mobile: 859.576.9151
Work Cell: 941.875.3369
E-mail: toni.almgren@bayer.com
Web: http://www.bayer.us